Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience-Reference-Cited by-同舟云学术

Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

Published:2017-10 Issue:10 Volume:34 Page:2232-2273
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Salles Gilles^ORCID,Barrett Martin,Foà Robin,Maurer Joerg,O’Brien Susan,Valente Nancy,Wenger Michael,Maloney David G.

Funder

F. Hoffmann-La Roche Ltd

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-017-0612-x.pdf

Reference166 articles.

1. Boffetta P. Epidemiology of adult non-Hodgkin lymphoma. Ann Oncol. 2011;22(Suppl 4):iv27–31.

2. Hallek M. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment. Am J Hematol. 2015;90:447–60.

3. National Cancer Institute. SEER cancer statistics review 1975–2013. Non-Hodgkin lymphoma. 2016. https://seer.cancer.gov/csr/1975_2013/results_merged/sect_19_nhl.pdf . Accessed 21 Jun 2017.

4. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.

5. Fisher SG, Fisher RI. The epidemiology of non-Hodgkin’s lymphoma. Oncogene. 2004;23:6524–34.

Cited by 431 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the inhibitory effects between bepotastine and diphenhydramine on rituximab-induced infusion-related reactions: A single-center retrospective study;2024-09-11

2. The efficacy of rituximab in the treatment of IgA vasculitis nephritis;Clinical and Experimental Medicine;2024-09-09

3. Development of a targeted IL-12 immunotherapy platform for B-cell lymphomas;International Immunopharmacology;2024-09

4. NK Cell Degranulation Triggered by Rituximab Identifies Potential Markers of Subpopulations with Enhanced Cytotoxicity toward Malignant B Cells;International Journal of Molecular Sciences;2024-08-18

5. Impact of leukemia-associated macrophages on the progression and therapy response of chronic lymphocytic leukemia;Leukemia Research;2024-08